Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 4 result(s)
Surrey Research Insight (SRI) is an open access resource that hosts, preserves and disseminates the full text of scholarly papers produced by members of the University of Surrey. Its main purpose is to help Surrey authors make their research more widely known; their ideas and findings readily accessible; and their papers more frequently read and cited. Surrey Research Insight (formerly Surrey Scholarship Online) was developed in line with the Open Access Initiative, promoting free access to scholarship for the benefit of authors and scholars. It is one of many open access repositories around the world that operate on agreed standards to ensure wide and timely dissemination of research.
This classic collection of test cases for validation of turbulence models started as an EU / ERCOFTAC project led by Pr. W. Rodi in 1995. It is maintained by Dr. T. Craft at Manchester since 1999. Initialy limited to experimental data, computational results, and results and conclusions drawn from the ERCOFTAC Workshops on Refined Turbulence Modelling (SIG15). At the moment, each case should contain at least a brief description, some data to download, and references to published work. Some cases contain significantly more information than this.
The COVID-19 pandemic has affected every country in the world. It is well documented that those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and those with underlying comorbidities. Therefore, patients requiring treatment for COVID-19 will also be on additional medication, posing a risk for drug-drug interactions (DDIs). In order to address this, the Liverpool Drug Interactions website team developed this freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.
ChemSpider is a free chemical structure database providing fast access to over 58 million structures, properties and associated information. By integrating and linking compounds from more than 400 data sources, ChemSpider enables researchers to discover the most comprehensive view of freely available chemical data from a single online search. It is owned by the Royal Society of Chemistry. ChemSpider builds on the collected sources by adding additional properties, related information and links back to original data sources. ChemSpider offers text and structure searching to find compounds of interest and provides unique services to improve this data by curation and annotation and to integrate it with users’ applications.